Esperion Therapeutics Inc (NASDAQ:ESPR) has a beta value of 1.00 and has seen 6.44 million shares traded in the last trading session. The company, currently
Esperion Therapeutics Inc (NASDAQ:ESPR) has a beta value of 1.00 and has seen 33.88 million shares traded in the last trading session. The company, currently
During the last session, Esperion Therapeutics Inc (NASDAQ:ESPR)’s traded shares were 8.22 million, with the beta value of the company hitting 1.00. At the end
During the last session, Esperion Therapeutics Inc (NASDAQ:ESPR)’s traded shares were 19.1 million, with the beta value of the company hitting 0.99. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
